BlueStar Genomics BlueStar Genomics
  • Our Story
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Our Approach
    • Epigenomics Platform
    • Publications & Posters
  • Our Tests
    • Overview
    • Pancreatic Cancer
    • Multi-cancer Panels
    • Clinical Trials
  • Our News
    • Press Releases
  • Join Our Team
    • Our Culture
    • Job Openings
    • Diversity Commitment
Select Page

Press Releases

Stay abreast of the news from Bluestar Genomics.

March 31, 2021
Bluestar Genomics Receives FDA Breakthrough Device Designation for First-of-Its-Kind Pancreatic Cancer Screening Test
January 29, 2020
Bluestar Genomics’ Breakthrough Study Highlights Promising Data for Multi-Cancer Detection From a Single Blood Draw
September 24, 2019
Bluestar Genomics to Share New Noninvasive Data for Earlier Cancer Detection at 11th CNAPs International Symposium
September 10, 2019
Bluestar Genomics Presents New Data Demonstrating Feasibility of a Novel Blood Test for Earlier Detection and Classification of Multiple Cancers
September 24, 2018
Bluestar Genomics Scientists Non-Invasively Detect Epigenomic Signatures of Early Pancreatic Cancer
<<12

Epigenomics-based Tests for Early Cancer Detection

Learn About Our Tests

Our Story

  • About Us
  • Leadership
  • Partnering
  • Contact

Our Approach

  • Epigenomics Platform
  • Publications & Posters

Our Tests

  • Overview
  • Pancreatic Cancer
  • Multi-cancer Panels
  • Clinical Trials

Our News

  • Press Releases

Join Our Team

  • Our Culture
  • Job Openings
  • Diversity Commitment
© 2022 Bluestar Genomics, Inc.
  • Privacy Policy
  • Terms of Use
BlueStar Genomics

The site uses cookies to improve the browsing experience. Please visit our Privacy Policy page for more information.

Accept